全文获取类型
收费全文 | 10253篇 |
免费 | 511篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 114篇 |
儿科学 | 177篇 |
妇产科学 | 224篇 |
基础医学 | 1180篇 |
口腔科学 | 257篇 |
临床医学 | 773篇 |
内科学 | 2791篇 |
皮肤病学 | 147篇 |
神经病学 | 1113篇 |
特种医学 | 297篇 |
外科学 | 1328篇 |
综合类 | 24篇 |
一般理论 | 3篇 |
预防医学 | 451篇 |
眼科学 | 204篇 |
药学 | 719篇 |
中国医学 | 14篇 |
肿瘤学 | 1003篇 |
出版年
2024年 | 6篇 |
2023年 | 60篇 |
2022年 | 121篇 |
2021年 | 264篇 |
2020年 | 164篇 |
2019年 | 211篇 |
2018年 | 241篇 |
2017年 | 213篇 |
2016年 | 242篇 |
2015年 | 260篇 |
2014年 | 352篇 |
2013年 | 525篇 |
2012年 | 759篇 |
2011年 | 783篇 |
2010年 | 420篇 |
2009年 | 408篇 |
2008年 | 714篇 |
2007年 | 760篇 |
2006年 | 748篇 |
2005年 | 701篇 |
2004年 | 692篇 |
2003年 | 615篇 |
2002年 | 553篇 |
2001年 | 67篇 |
2000年 | 56篇 |
1999年 | 51篇 |
1998年 | 109篇 |
1997年 | 75篇 |
1996年 | 78篇 |
1995年 | 77篇 |
1994年 | 73篇 |
1993年 | 63篇 |
1992年 | 43篇 |
1991年 | 31篇 |
1990年 | 36篇 |
1989年 | 29篇 |
1988年 | 18篇 |
1987年 | 20篇 |
1986年 | 21篇 |
1985年 | 16篇 |
1984年 | 19篇 |
1983年 | 18篇 |
1982年 | 17篇 |
1981年 | 24篇 |
1980年 | 11篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1972年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
111.
Carlo Gambacorti-Passerini Massimo Zucchetti Domenico Russo Roberta Frapolli Magda Verga Silvia Bungaro Lucia Tornaghi Fabio Rossi Pietro Pioltelli Enrico Pogliani Daniele Alberti Gianmarco Corneo Maurizio D'Incalci 《Clinical cancer research》2003,9(2):625-632
PURPOSE: Imatinib (Glivec) is a potent inhibitor of bcr/abl, an oncogenic fusion protein that causes chronic myelogenous leukemia (CML). alpha1 acid glycoprotein (AGP) binds to imatinib with high affinity and inhibits imatinib activity in vitro and in vivo in an animal model. A pharmacokinetics analysis of imatinib was undertaken in CML patients. EXPERIMENTAL DESIGN: Imatinib plasma concentrations were measured in 19 CML patients treated with imatinib (400 or 600 mg/day). Five patients received a concomitant short-term course of clindamycin (CLI). RESULTS: A positive correlation between AGP and imatinib plasma levels was observed. CLI administration decreased imatinib plasma concentrations, evaluated as area under the curve (AUC) and peak concentrations (C(max)). The effects of a bolus of CLI was studied in three patients on imatinib 23 h after the last imatinib dose. Within 5-10 min in three of three cases, CLI caused a decrease in imatinib plasma concentrations of 2.6-, 2.7-, and 4.7-fold, respectively. In vitro experiments using fresh blasts from CML patients showed that AGP, at concentrations observed in the patients, decreased imatinib intracellular concentrations up to 10 times and blocked imatinib activity. The incubation with CLI restored imatinib intracellular concentrations and biological activity. CONCLUSION: AGP exerts significant effects of the pharmacokinetics, plasma concentrations, and intracellular distribution of imatinib in CML patients; these data indicate that plasma imatinib levels represent unreliable indicators of the cellular concentrations of this molecule. 相似文献
112.
Mario Sanna Abdelkader Taibah Alessandra Russo Maurizio Falcioni Manoj Agarwal 《Otology & neurotology》2004,25(3):379-386
OBJECTIVE: Retrospective study and review of the complications other than those related to the facial nerve and hearing, encountered in acoustic neuroma surgery. Also, an evaluation of hospital stay and its relation with various factors. STUDY DESIGN: Retrospective case review. SETTING: Tertiary neurotologic and skull base referral center. PATIENTS: A series of 707 patients who underwent surgical removal of acoustic neuroma from April 1987 to December 2001. INTERVENTIONS: The surgical approaches used were the enlarged translabyrinthine approach, the enlarged middle fossa approach, and the retrosigmoid approach. In a small number of cases, the operations were performed through other approaches. MAIN OUTCOME MEASURES: The duration of hospital stay and appearance of complications in the perioperative period along with their management. Results related to the facial nerve and hearing were not considered in this study. RESULTS: The most frequent complication was abdominal subcutaneous hematoma (site of fat harvest), which occurred in 23 patients (3.2%). Cerebrospinal fluid leak was present in 20 patients (2.8%), 15 of whom needed revision surgery. Other complications included VIth cranial nerve dysfunction in 12 cases (1.68%), subdural hematoma in 3 cases (0.4%), cerebellopontine angle hematoma in 4 cases (0.6%), cerebellar edema in 2 cases (0.28%), brainstem hematoma in 1 case (0.14%), transitory aphasia in 1 case (0.14%), and lower cranial nerve dysfunction in 1 case (0.14%). Mortality occurred in only one case (0.14%). Medical complications seldom occurred. The postoperative hospital stay ranged from 2 to 36 days, with an average of 6.4 days. The overall hospital stay diminished over time from 10.2 days in 1987 to 1990, to 4.9 days in 2001. There was a significant relation between hospital stay and tumor size, approach used, and presence/absence of complications. CONCLUSIONS: Perioperative complications in acoustic neuroma surgery do exist, but this study demonstrated how low the incidence is. The authors believe that the low percentage of complications is mainly attributable to the majority of operations being carried out in specialized clinics, where they are considered routine operations. They believe that following individualized approaches, depending on tumor size and on the preoperative function of the cranial nerves, is the proper way to reach a significant reduction in complications while maintaining a high percentage of total tumor removal. The results of this study, considered as a basis of comparison with other studies, will certainly be useful in preoperative patient counseling. 相似文献
113.
Michele Iester Andrea Perdicchi Gianmaria Venturino Maurizio Rolando Carlo E Traverso Elvio Leonardi Giovanni Calabria 《Journal of ocular pharmacology and therapeutics》2004,20(5):393-400
PURPOSE: A drug utilization trial was performed to investigate acute versus short-term effects after switching or adding bimatoprost in open-angle glaucoma patients over a 3- month observation period. METHODS: One (1) eye was randomly chosen from 47 glaucomatous patients (abnormal visual field and/or abnormal optic nerve and intraocular pressure (IOP) above 21 mmHg without treatment). Only patients who did not reach the target IOP with their ongoing treatment were recruited in this study. IOP was measured at baseline, after 1 hour, and 2 hours from the first instillation and after 1 week, 1, and 3 months of treatment. RESULTS: The IOP before bimatoprost administration was 20.16+/-3.6 mmHg (mean+/-standard deviation). There was no statistically significant decrease of IOP after 1 hour (mean IOP, 19.96+/-4.25 mmHg) and after 2 hours (mean IOP, 17.73+/-3.24 mmHg). Statistically significant (p<0.001) decreases after 1 week (mean IOP, 16.48+/-2.9 mmHg), after 1 month (mean IOP, 16.48+/-2.9 mmHg) and after 3 months (mean IOP, 16.15+/-2.7 mmHg) were found. CONCLUSION: The results suggested that bimatroprost had a significant acute effect on IOP in monotherapy, while no significant effect was found when the therapy was switched or added. The effect for primary open-angle glaucoma was very evident. There was no specific side effect attributable to combining bimatoprost with any of the treatments in use. 相似文献
114.
男、女用避孕套临床可接受性的比较 总被引:4,自引:0,他引:4
目的:比较男、女用避孕套的临床可接受性。方法:以40名健康育龄期妇女自愿者为研究对象,采用交叉设计,每人使用男女用避孕套各5个,每使用完一种后填写评价性调查表;使用完两种后,填写总结性调查表,对两种避孕套进行比较。结果:在避孕套的取出/取下、性生活中阴茎的插入、以及性生活中是否感觉不舒服(疼痛、烧灼感)等方面,对两种避孕套的评价基本相同。男用避孕套的主要优点是易学、易用,而女用避孕套可使性生活更有兴趣和感到更安全。总的说来,女性对使用两种避孕套的态度没有明显差异,而男性则比较喜欢使用男用避孕套。结论:通过适当的推广和改进,在我国会有一定比例的育龄妇女接受并使用女用避孕套。 相似文献
115.
Filippo Festini Riccardo Ciuti Giovanni Taccetti Teresa Repetto Silvia Campana Maurizio De Martino 《The journal of maternal-fetal & neonatal medicine》2006,19(6):375-376
We report the case of a 30-year-old woman with cystic fibrosis (CF) chronically infected with Pseudomonas aeruginosa who delivered and breast-fed a healthy boy. While breast-feeding the woman had to undergo an i.v. antibiotic course with tobramycin, due to pulmonary exacerbation. Tobramycin was not detected in her milk and lactation could be continued. This is the first time that the presence of tobramycin in the milk of a CF woman during i.v. administration has been investigated. 相似文献
116.
Cristina Bosetti Luana Spertini Maria Parpinel Patrizia Gnagnarella Pagona Lagiou Eva Negri Silvia Franceschi Maurizio Montella Julie Peterson Johanna Dwyer Attilio Giacosa Carlo La Vecchia 《Cancer epidemiology, biomarkers & prevention》2005,14(4):805-808
Few epidemiologic studies have investigated the potential relation between flavonoids and breast cancer risk. We have applied recently published data on the composition of foods and beverages in terms of six principal classes of flavonoids (i.e., flavanones, flavan-3-ols, flavonols, flavones, anthocyanidines, and isoflavones) on dietary information collected in a large-case control study of breast cancer conducted in Italy between 1991 and 1994. The study included 2,569 women with incident, histologically confirmed breast cancer, and 2,588 hospital controls. Odds ratios (OR) and 95% confidence intervals were estimated by multiple logistic regression models. After allowance for major confounding factors and energy intake, a reduced risk of breast cancer was found for increasing intake of flavones (OR, 0.81, for the highest versus the lowest quintile; P-trend, 0.02), and flavonols (OR, 0.80; P-trend, 0.06). No significant association was found for other flavonoids, including flavanones (OR, 0.95), flavan-3-ols (OR, 0.86), anthocyanidins (OR, 1.09), as well as for isoflavones (OR, 1.05). The findings of this large study of an inverse association between flavones and breast cancer risk confirm the results of a Greek study. 相似文献
117.
Dietary folate and risk of prostate cancer in Italy. 总被引:2,自引:0,他引:2
Claudio Pelucchi Carlotta Galeone Renato Talamini Eva Negri Maria Parpinel Silvia Franceschi Maurizio Montella Carlo La Vecchia 《Cancer epidemiology, biomarkers & prevention》2005,14(4):944-948
Folate status may affect cancer risk through its role in both methylation and nucleotide synthesis of DNA. A low dietary intake of folate has been linked to risk of several cancers, but epidemiologic studies with reference to prostate cancer are scanty. We therefore analyzed data from a case-control study of prostate cancer conducted between 1991 and 2002 in various areas of Italy. Cases were 1,294 patients with incident, histologically confirmed prostate cancer and controls were 1,451 patients admitted to the same network of hospitals of cases for acute, nonneoplastic conditions. All subjects were < 75 years old. Intake of folate and other nutrients was computed from a validated food frequency questionnaire. We adjusted for energy intake using the residual method, and calculated multivariate odds ratios (OR) and 95% confidence intervals (CI) using unconditional logistic regression. The OR of prostate cancer was 0.66 (95% CI, 0.51-0.85) for the highest versus the lowest quintile of folate intake. The relation between dietary folate and prostate cancer was consistent across strata of age, methionine, vitamin B6, and alcohol intake, and did not vary substantially according to Gleason score of prostate cancer. The combined OR for high-folate and low-alcohol intake versus low-folate and high-alcohol intake was 0.46 (95% CI, 0.29-0.75). Therefore, this study supports a favorable role of dietary folate on prostate cancer risk. 相似文献
118.
Andrea Pession Maria Grazia Valsecchi Giuseppe Masera Willem A Kamps Edina Magyarosy Carmelo Rizzari Elisabeth R van Wering Luca Lo Nigro Anna van der Does Franco Locatelli Giuseppe Basso Maurizio Aricò 《Journal of clinical oncology》2005,23(28):7161-7167
PURPOSE: Between September 1991 and May 1997, within the International Berlin-Frankfurt-Muenster Study Group (I-BFM-SG), a randomized study was performed aimed at assessing the efficacy of prolonged use of high-dose l-asparaginase (HD-l-ASP) during continuation therapy in children with standard risk (SR) acute lymphoblastic leukemia (ALL), treated with a reduced BFM-type chemotherapy. PATIENTS AND METHODS: The Italian, Dutch, and Hungarian groups participated in this study denominated IDH-ALL-91, and 494 children were enrolled. Treatment consisted of a BFM-type modified backbone with omission of the IB part in induction and elimination of two doses of anthracyclines during reinduction in both arms at the beginning of continuation therapy. Patients were randomly assigned to receive (YES-ASP) or not (NO-ASP) 20 weekly HD-l-ASP (25,000 IU/m2). RESULTS: The event-free-survival and overall survival probabilities at 10 years for the entire group were 82.5% (1.8) and 90.3% (1.3), respectively. Of the 490 patients eligible for random assignment, 355 (72.4%) were randomly assigned (178 YES-ASP and 177 NO-ASP). After a median follow-up of 9 years, the probability of disease-free survival at 10 years was 87.5% (SE, 2.5) for YES-ASP arm versus 78.7% (SE, 3.3) for NO-ASP arm (P = .03). In multivariate analysis, NO-ASP arm (P = .03), male sex (P = .004), and age older than 10 years (P = .0003) had a significantly adverse impact on outcome. CONCLUSION: In this subset of patients, selected with criteria not including monitoring of minimal residual disease, application of extended HD-l-ASP may improve prognosis, compensating reduced leukemia control that results from adoption of a reduced-intensity BFM-backbone for treatment of children with SR ALL. 相似文献
119.
120.